Andria Ford
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA (NCT05334576) | Andria Ford | 2022-08-01 |
Track Andria Ford automatically
Every clearance here is in the API, with alerts when new ones post.